C - Reactive Protein (CRP) Testing Market is poised to register a CAGR of 1.5% by 2023 – Top Players: ABAXIS, ABBOTT, DANAHER, HOFFMANN-LA ROCHE LTD., LABORATORY CORPORATION OF AMERICA HOLDINGS, MERCK KGAA, QUEST DIAGNOSTICS.

Market Analysis:

United States to Dominate the Market

The United States is one of the primary markets for critical care diagnostics, and it is expected to dominate the market in the forecast period due to the presence of established multinational players such as LabCorp with multiple manufacturing plants, technological advancements, and well-established healthcare infrastructure.

Detailed Sample Copy of Updated Analysis @ https://marketprognosis.com/sample-request/16833
Note: “If this link doesn’t work in Internet Explorer, kindly try pasting it in other browsers.”

As per the various investigational studies conducted by the National Cancer Institute and the American Association for Cancer Research, showed elevated CRP levels for lungs cancers and colorectal cancer mortality, attracting many companies for investing in the research and development in CRP tests, raising its demand for treatment as well as early diagnosis of the diseases. Potential factors driving this market are increasing global incidence of endometriosis in women, the rise in funding toward the technological advancement in testing devices, as well as, the rise in the adoption of point of care devices. But still there is lack of public awareness for CRP Tests.

Request Discount on this report @ https://marketprognosis.com/discount-request/16833
Note: “If this link doesn’t work in Internet Explorer, kindly try pasting it in other browsers.”

Market Segments:
C - Reactive Protein (CRP) Testing Market is segmented by:
1. Assay Type: Enzyme-linked Immunosorbent Assay (ELISA), Chemiluminescence Immunoassay (CLIA), Immunoturbidimetric Assay, Others
2. Application: Diabetes, Rheumatoid Arthritis, Cardiovascular Diseases, Inflammatory Bowel Disease, Cancer, Others
3. Geography: North America, South America, Europe, Asia Pacific, Middle East & Africa

Key Developments in the Market
• January, 2018 - Meso Scale Diagnostic Llc, received 510 (k) clearance from the US FDA for its conventional C-reactive protein assay for in vitro diagnostic use in the United States.

Enquiry before Buying @ https://marketprognosis.com/enquiry/16833
Note: “If this link doesn’t work in Internet Explorer, kindly try pasting it in other browsers.”

About Market Prognosis
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today's complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:
ProgMark Pvt Ltd,
Thane - 421501
India.
Contact No: +1 973 241 5193
Email: sales@marketprognosis.com

This release was published on openPR.